☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
All Posts by Date
Disease of the Month: IgA Nephropathy
March 13, 2023
Sanofi to Acquire Provention Bio for ~$2.9B
March 13, 2023
Calliditas’ Nefecon Meets its Primary Endpoint in P-III Trial (NefIgArd) for the Treatment of IgA Nephropathy
March 13, 2023
Acadia’s Daybue (trofinetide) Receives the US FDA’s Approval for Rett Syndrome in Adult and Pediatric Patients Aged ≥2Years
March 13, 2023
Guardant Health Reports the Submission of Premarket Approval Application to the US FDA for Shield Blood Test to Detect Colorectal...
March 13, 2023
AnnJi Entered into an Exclusive License Agreement with Avenue Therapeutics to Develop and Commercialize AJ201 for Kennedy's Diseas...
March 13, 2023
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions
Modal title
×
Modal body text goes here.